Celcuity Inc. Reports Third Quarter 2021 Financial Results and Provides Corporate Update

On track to obtain FDA feedback and initiate a Phase 3 study for gedatolisib during the first half of 2022Will present updated Phase 1b data during a Spotlight Poster Discussion Session at the 2021 San Antonio Breast Cancer Symposium in December …